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Abstract Hydrocephalus includes a range of disorders characterised by clinical 
symptoms, abnormal brain imaging and altered cerebrospinal fluid (CSF) dynamics. 
Infusion tests are one of the available procedures to study CSF circulation in patients 
with clinical and radiological features of hydrocephalus. In them, intracranial pressure 
(ICP) is deliberately raised and CSF circulation disorders evaluated through 
measurements of the resulting ICP. In this study, we analysed seventy-seven ICP 
signals recorded during infusion tests using four spectral-based parameters: median 
frequency (MF) and relative power (RP) in three frequency bands. These measures 
provide a novel perspective for the analysis of ICP signals in the frequency domain. 
Each signal was divided into four artefact-free epochs (corresponding to the basal, early 
infusion, plateau and recovery phases of the infusion study). The four spectral 
parameters were calculated for each epoch. We analysed differences between epochs of 
the infusion test and correlations between these epochs and patient data. Statistically 
significant differences ( 3107.1 p , Bonferroni-corrected Wilcoxon signed-rank tests) 
were found between epochs of the infusion test using MF and RP. Furthermore, some 
spectral parameters (MF in the basal phase, RP for the first frequency band and in the 
early infusion phase, RP for the second frequency band and in all phases of the infusion 
study and RP in the third frequency band and in the basal phase) revealed significant 
correlations ( 01.0p ) between epochs of the infusion test and signal amplitude in the 
basal and plateau phases. Our results suggest that spectral analysis of ICP signals could 
be useful for understanding CSF dynamics in hydrocephalus. 
 
Keywords Hydrocephalus, infusion test, intracranial pressure, median frequency, 
relative power. 
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1. INTRODUCTION 
The term hydrocephalus encompasses a range of disorders characterised by clinical 
symptoms, abnormal brain imaging and derangement of cerebrospinal fluid (CSF) 
dynamics [1]. It can appear as a primary condition or as a secondary effect to head 
trauma, brain tumour or meningitis [2]. Implantation of a CSF shunt is a standard way 
of managing hydrocephalus [3]. However, some patients may not respond to this 
treatment and their condition becomes complex for neurosurgeons [2]. The study of 
intracranial pressure (ICP) and CSF dynamics can help in the decision about performing 
shunt placement surgery in a patient with hydrocephalus and can also provide valuable 
information for shunted patient management [3]. Several efforts have been made to find 
a relationship between parameters that characterise CSF dynamics and the outcome of 
shunting. Previous studies provided reference values that could be used for comparison 
when exploring disturbances in CSF dynamics. However, the recording protocol and the 
results vary among studies. Some authors reported a mean resting pressure of 1.38 kPa 
(approximately 10.35 mmHg) on 100 patients lying in the supine position for data 
recording [4]. In a more recent study [5], lumbar puncture was performed on patients 
lying on their side on the examination table. They obtained resting pressure values of 
9.4 ± 4.6 mmHg in 151 patients at risk for normal pressure hydrocephalus (NPH). These 
values are lower than those found in another study on 40 healthy (no psychiatric or 
neurologic disorders) elderly subjects, where a median resting pressure of 11.6 mmHg 
was obtained while patients lied on the supine position during data recording [6]. These 
differences show that further research is needed to better understand CSF dynamics and 
to improve clinical management of patients with hydrocephalus. 
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Infusion tests, also known as infusion studies, are routinely performed to analyse 
CSF circulation in patients with clinical and radiological features of hydrocephalus. In 
infusion studies, ICP is deliberately raised by the introduction of fluid in the ventricular 
or subarachnoidal space. The resulting ICP is recorded, usually in the lumbar 
subarachnoidal space, and CSF outflow resistance is calculated [7]. Infusion studies are 
commonly performed as predictive tests in patients with NPH, but its applications also 
include prediction of patient response to shunting and assessment of shunt function [8]. 
Additionally, clinical and experimental studies have relied on infusion tests to analyse 
metabolic changes in the periventricular white matter [9] and haemodynamic responses 
associated with the increase of ICP [10]. Computerised infusion tests [11, 12] are a 
modification of the conventional constant rate infusion test, originally described by 
Katzman [13]. 
Some therapies in severe traumatic brain injury or hydrocephalus are based on the 
ICP time-averaged mean [7, 14]. However, this parameter does not account for all the 
information that can be extracted from the ICP waveform and does not provide 
physicians with a deep insight into cerebral mechanisms of autoregulation [7, 14]. 
Several methods have been developed in order to better understand ICP and CSF 
circulation disorders. Some of them rely on the non-linear analysis of ICP signals, using 
parameters like approximate entropy [15, 16] and Lempel-Ziv complexity [7, 17]. The 
results of these studies revealed a decomplexification in the ICP signal during episodes 
of intracranial hypertension in paediatric patients with traumatic brain injury [15, 17] 
and in adults with hydrocephalus during infusion studies [7]. Spectral analysis of ICP 
signals recorded using different techniques has been also addressed in previous studies 
[10, 18-20]. However, the approaches are quite different. Some authors analysed the 
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relationship between three spectral components of the ICP waveform and the resistance 
to CSF outflow in infusion studies in order to explore the ability of new indexes in the 
prediction of the response to shunting [10]. Nevertheless, the differences among phases 
of the infusion test were not analysed. Other studies focused on the analysis of very low 
frequency components, called slow waves, and their relationship with physiological 
processes [18]. As a consequence, their analysis did not explore frequencies above 0.2 
Hz. Several indexes that quantify the signal spectrum waveform were analysed in [19] 
to explore the differences in the shape of the waveform for different conditions. A 
continuous monitoring of ICP was required to obtain the recordings. The reconstruction 
of the ICP signal from the information contained in its first harmonic was addressed by 
Holm and Eide [20]. However, their frequential analysis relied only on the first 
harmonic of the Fourier transform of the signal. Further work should be developed to 
improve the spectral characterisation of ICP signals and to assess the potential of this 
approach in the clinical practise. 
The present study is a new effort to explore the ability of several spectral based 
measures to characterise ICP signals recorded during infusion tests in patients with 
hydrocephalus. We studied the following spectral parameters: median frequency (MF) 
and relative power (RP) in three frequency bands. The aims of this study were: (i) to test 
whether MF and RP could reveal significant differences among phases of the infusion 
study, (ii) to explore the relationship between spectral parameters and some 
demographic, radiological and ICP-based variables recorded for the patients in our 
database and (iii) to introduce an alternative framework to understand brain dynamics in 
hydrocephalus. 
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2. MATERIALS AND METHODS 
2.1. Subjects  
A database of 77 ICP signals from patients suffering from hydrocephalus of various 
types and origin (41 male and 36 female, with age 74 [62-80] years, median 
[interquartile range, IQR]), was retrospectively analysed in this study. Data were 
recorded during infusion tests at the Department of Neurosurgery of the University 
Hospital of León (Spain). Brain imaging (computer tomography or magnetic resonance) 
revealed evidence of ventricular dilation (Evans index ≥ 0.30) in all of them. Patients 
also showed other symptoms of NPH, such as poor motor balance, cognitive 
impairment or urinary incontinence. The absence of a previous history indicated 
idiopathic NPH in 45 patients. In 24 patients, a secondary form of NPH developed as a 
consequence of a preceding history of subarachnoid haemorrhage, traumatic brain 
injury, stroke or intracranial neoplasm. In the remaining 8 cases, the infusion study was 
conducted to control shunt dysfunction. Lumbar infusion tests were performed on this 
population as a supplementary hydrodynamic study and as an aid in the decision on the 
surgical management of patients [7]. Clinical data of the population under study are 
summarised in Table 1. 
In all cases, patients or a close relative gave their informed consent to participate in 
the study, which was approved by the local ethics committee. 
------------------------------------------------------------------------------------------------------- 
INSERT TABLE 1 AROUND HERE 
------------------------------------------------------------------------------------------------------- 
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2.2. ICP data recording 
Infusion studies were performed using a variant of the method described by Katzman 
and Hussey [13]. Under local anaesthesia, patients were positioned in the lateral 
recumbent position and two needles were inserted in their lower lumbar region. The 
first one (caudal needle) was connected to an infusion pump (Lifecare
®
 5000, Abbott 
Laboratories). For pressure measurement, a three way stopcock equipped with a short 
extension line was connected to the second needle (rostral cannula). Then, a pressure 
microtransducer (Codman
®
 MicroSensor
TM
 ICP transducer, Codman & Shurtleff) was 
introduced through the hole of a fenestrated male Luer lock connected to the three-way 
stopcock. The tip of the pressure microtransducer was pushed inside the extension line 
towards the lumbar needle. Finally, the transducer was secured in its position, rotating 
the male Luer lock and tightening the fenestrated cap to avoid CSF leakage. The 
pressure signal from the analogue output of the microtransducer monitor was 
subsequently amplified (ML110 Bridge amplifier) and digitised (PowerLab 2/25 Data 
recording system ML825, ADI Instruments). The analogue to digital converter was also 
connected to a computer in order to visualise and record the ICP signals [7]. 
After 5 minutes of baseline recording, basal pressure ( oP ) was determined. Then, 
Ringer solution at a constant infusion rate ( IR ) of 1.5 ml/min was infused until a 
plateau was reached. Once the infusion was stopped, CSF pressure continued to be 
recorded until it decreased towards the baseline level [7]. The plateau CSF pressure 
( pP ) and oP  were used to obtain the CSF outflow resistance ( R ) as follows [7]: 
IR
PP
R
p 0
 . (1) 
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For each of the 77 recordings, an experienced neurosurgeon selected four artefact-
free epochs, representative of the four phases of the infusion test [7]: 
 Epoch 0 corresponds to the basal phase of the infusion test. oP  was determined in 
this stage. 
 Epoch 1 is representative of the early infusion phase and usually describes an 
ascending slope. 
 Epoch 2 corresponds to the plateau phase. pP  was obtained in this stage. 
 Epoch 3 represents the recovery phase, once the infusion has stopped and the ICP 
signal returns slowly to levels of the basal state. 
The four artefact-free epochs have been represented for one of the ICP signals in 
Figure 1a. 
------------------------------------------------------------------------------------------------------- 
DISPLAY FIGURE 1 AROUND HERE 
------------------------------------------------------------------------------------------------------- 
ICP recordings were acquired with a sampling frequency fs=100 Hz (Ts= 1/fs = 0.01s, 
where Ts is the sampling period). Besides, all the recordings were processed using a 
finite impulse response (FIR) bandpass filter with cut-off frequencies 0.1 Hz and 10 Hz. 
This frequency range preserved the relevant spectral content of the signals and 
minimised the presence of the DC component. 
2.3. Calculation of spectral parameters 
The Fourier transform (FT) is commonly used to analyse the spectral content of 
signals. In order to establish a mathematical framework, we assume that each ICP 
recording is a time signal x(t) sampled at frequency fs (fs=100 Hz in this study). The 
resulting discrete-time signal can be denoted by x[n] = x(nTs), n = 0,…, N–1, where 
 9 
x[n] has N samples. The discrete-time Fourier series (DTFS) can be computed to 
analyse the spectral content of x[n] as follows [21]: 
njk
N
n
enxkX 0
1
0
][][



 , 1,,0  Nk  ,  (2) 
where 0 = 2/N is the fundamental frequency and k identifies the frequency of the 
sinusoid associated with X[k]. The discrete frequency can be obtained as  = k0 [22]. 
The power spectral density (PSD) is generally used instead of the DTFS to 
characterise the distribution of signal power with frequency [23, 24]. It can be computed 
as the FT of the autocorrelation function of x[n], as they are Fourier transform pairs 
according to the Wiener-Khintchine-Einstein theorem [23, 25]. In the case of non-
stationary signals, the spectral analysis must be performed considering their time-
varying properties. Thus, the PSD is obtained in this case as the DTFS of the Short-
Time Autocorrelation (STA) function. The STA function extends the definition of the 
autocorrelation function using the time sliding window algorithm [26, 27]. A moving 
window of 5 s with an overlap of 4 s was used in this study [7]. Each ICP signal was 
thus divided into NT segments of 5 s, whose length was L (500 samples). The STA 
function of x[n], ],[, umR wxx , was computed as follows: 
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where w[n] is the temporal window of length L and w[n]=w[-n]. 
The PSD, ],[, kmS wx , was then calculated as the DTFS of the STA [22]: 
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It should be noted that Bendat and Piersol’s runs test, a general test for wide-sense 
stationarity, was used to assess stationarity in the 5-s signal segments [28]. 
Four spectral based measures were subsequently calculated from the PSD: the MF 
and the RP in three frequency bands of interest. These parameters were computed from 
two different points of view. Firstly, the temporal evolution of these parameters was 
computed from  kmS wx ,,  to obtain a value for every second beyond the fifth. Secondly, 
we averaged the temporal evolution of these parameters in the four artefact-free epochs 
in which the infusion test was divided. 
MF offers a simple means of summarising the whole spectral content of the PSD [23]. 
It is defined as the frequency that comprises 50% of the signal power. It can be 
computed as [23]: 
   
 



mr
rk
wx
r
rk
wx
MF
kmSkmS
1.0
10
1.0
,,5.0 ,, , 1,,0  Lk  ; 1,,0  TNm  , (5) 
where 1.0r  represents the discrete-time frequency corresponding to 0.1 Hz linear 
frequency, 10r  represents the discrete-time frequency corresponding to a linear 
frequency of 10 Hz and  mrMF  is the discrete MF. To obtain the continuous-time MF, 
the following relationship should be applied: 
   mr
L
f
mMF MF
s  , 1,,0  TNm  . (6) 
Figure 1b depicts the variation of MF along the duration of the example ICP signal in 
Figure 1a. 
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The RP in several bands of interest was also calculated from the PSD. To the best of 
our knowledge, these bands of interest have not been standardised for ICP signals 
recorded during infusion studies. Thus, in a first step, we analysed the PSD of the 
signals in our database to experimentally determine a suitable frequency division. For 
this task, we obtained an average PSD for the complete data set, ][kSav . This was 
done by computing the mean PSD for each subject in the database i ( 771  i ), 
][_ kS ix , and normalising it to the range 0-1 [24], ][_ kS in . ][kSav  was obtained as 
the mean of ][_ kS in  for 771  i . The normalisation process ensured that the PSD of 
all subjects was in the same range when computing ][S kav . ][kSav  showed two main 
peaks between 0.1 Hz and 3 Hz. The first one could be found between 0.1 Hz and 1 Hz, 
while the second one fell between 1 Hz and 2 Hz. We could also find some spectral 
components of the ICP signals in frequencies higher than 2 Hz, but the magnitude of 
][S kav  was significantly lower for these frequencies, especially for frequencies above 
3 Hz. This was also the average behaviour in ][_ kS in . On the basis of the previous 
results, we considered three frequency bands: “band 1” between 0.1 Hz and 1 Hz ( 1B ), 
“band 2” between 1 Hz and 2 Hz ( 2B ) and “band 3” between 2 Hz and 3 Hz ( 3B ). 
These bands comprise most of the ICP signal spectral content (including the two 
maxima in ][S kav ). Their width (of approximately 1 Hz) provides an exhaustive 
analysis of ICP signal spectrum. In a second step, we studied RP in 1B , 2B  and 3B . The 
parameter RP was calculated as the power of the signal in the band of interest divided 
by the power in the complete frequency range. Its definition can be read as [29]: 
 12 
  


j
j
Bk
winB kmSmRP ],[,_ , 1,,0  Lk  , 1,,0  TNm  ,  (7) 
where jB  denotes the band of interest ( 1B , 2B  or 3B ) and ],[,_ kmS win  is the 
normalised PSD for each subject i. It should be noted that the frequency limits of the 
bands in eq. 7 are discrete frequencies. However, a discrete frequency k is directly 
related to continuous time frequency f as follows: f=fsk/L. The temporal variation of 
1B
RP , 
2B
RP  and 
3B
RP  for the example ICP signal is shown in Figure 1c. 
2.4. Statistical analysis 
Initially, the Kolmogorov–Smirnov test with Lilliefors significance correction and 
the Shapiro–Wilk test for normality were used to verify the normality of the spectral 
parameters in the 4 artefact-free epochs of the infusion study. After this exploratory 
analysis, we found that the parametric assumptions did not hold. For this reason, the 
non-parametric Friedman test was used to determine whether statistically significant 
differences ( 01.0 ) could be found in pairwise comparisons between epochs of the 
infusion test [30]. In the cases where these differences existed, post hoc analyses were 
carried out using the Wilcoxon signed-rank test with Bonferroni correction to account 
for multiple comparisons ( 3107.16/01.0  ) [30]. The Z score and p-value 
associated to this test were obtained. 
Spearman’s correlation was used to analyse the relationship between phases of the 
infusion test and patient data in Table 1. A significance level 01.0  was also 
considered here. 
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3. RESULTS 
3.1. Design considerations and notation 
The first objective of this study was to determine whether the proposed spectral 
parameters could reveal statistically significant differences between stages of the 
infusion test. For this task, the spectral parameters defined in the previous section were 
calculated for each subject and artefact-free epoch in which the infusion test was 
divided. Firstly, the PSD of the ICP signals was calculated as the FT of the 
autocorrelation function of 5-s segments of the signal. A moving window of 5 s with an 
overlap of 4 s was used until the last sample of the signal was reached [23]. The 
stationarity of the 5-s segments of the signal was investigated using the Bendat and 
Piersol’s runs test [28]. We found that all the segments were stationary. Thus the 
proposed spectral analysis is appropriate in this study. Secondly, the four spectral 
parameters were calculated to obtain a value for every second beyond the fifth. Finally, 
the spectral parameters were averaged in the four artefact-free epochs of the infusion 
test. Thus, a single value of MF, 
1B
RP , 
2B
RP  and 
3B
RP  was obtained for each subject 
and artefact-free epoch. We will denote by 0MF  the MF value in the basal phase of the 
infusion test, by 1MF  the MF value in epoch 1, by 2MF  the MF value in the plateau 
phase and by 3MF  the MF value in the recovery phase. Similarly, 0
jB
RP , 1
jB
RP , 
2
jB
RP  and 3
jB
RP  ( 3 2, 1,j ) represent the values of RP calculated for phases 0, 1, 2 
and 3 of the infusion test, respectively. 
In a second stage, we analysed whether these spectral parameters could reveal 
significant correlations between phases of the infusion test and the clinical data of the 
patients. For this task, the Spearman’s correlation coefficient between spectral 
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parameters in each artefact-free epoch and the patient data included in Table1 was 
calculated. 
Table 2 summarises the median [IQR] values of the epoch length, CSF pressure and 
spectral parameters (MF, 
1B
RP , 
2B
RP  and 
3B
RP ) for the artefact-free epochs of the 
infusion test. These values were averaged over the 77 subjects in our database. 
------------------------------------------------------------------------------------------------------- 
INSERT TABLE 2 AROUND HERE 
------------------------------------------------------------------------------------------------------ 
3.2. Differences in pairwise comparisons between stages of the infusion test 
Our results showed that the lowest MF values were obtained in the basal epoch, then 
increased during infusion to reach the highest values in the plateau phase and, finally, 
decreased again in the recovery phase, reaching values close to those in the basal epoch 
(see Table 2). The Kolmogorov–Smirnov test with Lilliefors significance correction and 
Shapiro–Wilk test for normality revealed that 0MF , 1MF , 2MF  and 3MF  were not 
normally distributed ( 01.0p ). The Friedman test revealed significant interactions 
among the MF values in the various stages of the infusion study 
( 27.44)3(2  , 01.01033.1 9  p ). In order to explore these interactions, post hoc 
analyses were carried out using the Wilcoxon signed-rank test with Bonferroni 
correction. Statistically significant differences were found between the following pairs: 
0MF  vs. 1MF  ( 42.3Z , 41027.6 p ), 0MF  vs. 2MF  ( 50.4Z , 
61092.6 p ), 0MF  vs. 3MF  ( 42.4Z , 510p ) and 1MF  vs. 2MF  
( 89.4Z , 61002.1 p ). These results are summarised in Table 3. 
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------------------------------------------------------------------------------------------------------- 
INSERT TABLE 3 AROUND HERE 
------------------------------------------------------------------------------------------------------- 
Regarding RP, the behaviour was different for each band of interest. In the case of 
1B
RP , values in the basal epoch were the highest (41.74[25.66-60.19] %, median[IQR]), 
then decreased during infusion to reach the lowest values in the plateau phase 
(21.76[12.03-42.98] %, median[IQR]) and increased again in the recovery phase 
(28.28[12.78-45.58] %, median[IQR]) to values that were closer to those in the basal 
epoch. However, for 
2B
RP  the trend was different. 
2B
RP  values in the basal epoch were 
the lowest (39.41[21.05-56.85] %, median[IQR]), then increased during infusion and 
reached the highest values in the plateau phase (64.01[43.48-75.94] %, median[IQR]). 
They decreased again in the recovery phase (60.48[44.91-73.83] %, median[IQR]) to 
values that were closer to those in the basal phase. In the case of 
3B
RP , we could not 
determine a clear tendency, as the values of 
3B
RP  were very similar in all phases 
(5.97[4.02-9.64] % for the basal phase, 6.01[3.99-8.18] % for the early infusion phase, 
6.24[3.50-8.11] % for the plateau phase and 6.25[3.70-8.18] % for the recovery phase, 
all the values given as median[IQR]). 
The Kolmogorov–Smirnov test with Lilliefors significance correction and Shapiro–
Wilk test revealed that the normality hypothesis did not hold for these variables. 
Therefore, we carried out a Friedman test to determine whether differences between 
stages of the infusion study could be found using 
1B
RP , 
2B
RP  and 
3B
RP . The results 
revealed significant interactions for 
1B
RP  ( 08.58)3(2  , 121051.1 p ) and 
2B
RP  
( 99.107)3(2  , 231097.2 p ), whereas no significant interaction was found for 
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3B
RP  ( 03.2)3(2  , 57.0p ). Consequently, post hoc analyses were carried out only 
for 
1B
RP  and 
2B
RP . The results of the Wilcoxon signed-rank tests for these parameters 
are included in Table 3. Significant differences could be found among all epochs of the 
infusion test with both parameters. The magnitude of these differences ranged from 
71.5Z  ( 81013.1 p ) for the comparison 1
1B
RP  vs. 2
1B
RP  to 36.3Z  
( 41070.7 p ) for 1
1B
RP  vs. 3
1B
RP , in the case of 1B . Regarding 2B , the minimum Z 
score was 95.6Z  ( 121069.3 p ) for 0
2B
RP  vs. 2
2B
RP  and the maximum Z score 
reached 98.3Z  ( 51094.6 p ) in the case of 1
2B
RP  vs. 3
2B
RP . 
3.3. Correlation with patient data 
We also wanted to know whether the spectral parameters calculated in this study 
could reveal any relationship between phases of the infusion tests and some 
demographic, radiological and ICP-based parameters recorded for the 77 patients that 
participated in the study. They are summarised in Table 1 and include: age, Evans index 
( E ), oP , basal amplitude of the CSF pressure signal ( oA ), pP , plateau amplitude of the 
CSF pressure signal ( pA ) and R . 
The correlation between the spectral parameters ( 0MF , 1MF , 2MF , 3MF , 0
jB
RP , 
1
jB
RP , 2
jB
RP  and 3
jB
RP , with 3 2, 1,j ) and patients data was analysed using the 
Spearman’s correlation coefficient, r . The results are summarised in Table 4. Only a 
few significant correlations ( 01.0p ) were found. In the case of MF, only the 
correlation oA  vs. 0MF  was statistically significant ( 3164.0r , 0051.0p ). 
Similarly, only one significant correlation was found for 
1B
RP  and 
3B
RP , with the pairs 
 17 
pA  vs. 11BRP  ( 2960.0r , 0090.0p ) and oA  vs. 03BRP  ( 3599.0r , 0013.0p ). 
Finally, statistically significant correlations could be also found for the pairs pA  vs. 
0
2B
RP  ( 4132.0r , 0002.0p ), pA  vs. 12BRP  ( 4438.0r , 0001.0p ), pA  vs. 
2
2B
RP  ( 3436.0r , 0022.0p ) and pA  vs. 32BRP  ( 3496.0r , 0018.0p ). 
------------------------------------------------------------------------------------------------------- 
INSERT TABLE 4 AROUND HERE 
------------------------------------------------------------------------------------------------------- 
4. DISCUSSION AND CONCLUSION 
In this study, a spectral characterisation of ICP signals recorded during infusion tests 
in patients suffering form hydrocephalus was carried out. The four phases, in which 
infusion tests in our database were divided, were analysed by means of four spectral 
parameters: MF, 
1B
RP , 
2B
RP  and 
3B
RP . Although ICP has been previously analysed 
from different points of view, this is, to the best of our knowledge, the first study that 
addresses the spectral analysis of ICP signals recorded during infusion studies using 
parameters like MF or RP. 
Spectral parameters were computed from the PSD of the ICP signals. This is a useful 
tool to analyse the spectral content of signals. In this study, the PSD was calculated as 
the DTFS of the STA function, as the signals under analysis were non-stationary. 
However, it should be noted that this is not the only available procedure to calculate the 
PSD [31]. The Welch’s method, based on the averaging of modified periodograms, has 
been also used with this purpose [31, 32]. 
Firstly, we assessed whether the spectral parameters could reveal differences among 
phases of the infusion study. Results for MF in Table 3 show that significant differences 
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were found between all phases of the infusion test, except in the comparisons 2MF  vs. 
3MF  and 1MF  vs. 3MF . A possible explanation could be that, in the recovery phase, 
the ICP signals tend to gradually return to the basal state. However, the recording time 
may not be long enough for the ICP signals to exactly match the characteristics in the 
basal phase. Therefore, the MF values in the recovery phase may not be too different 
from those in the plateau phase or early infusion phase (see Table 2). 
Regarding RP, significant differences were found among all phases of the infusion 
study using 
1B
RP  and 
2B
RP , but differences were not statistically significant in the case 
of 
3B
RP . These results suggest that low frequency components of the ICP signal (bands 
1B  and 2B ) change significantly during stress episodes, such as the increase in ICP 
produced by infusion studies. On the contrary, high frequency components (band 3B ) 
are not sensitive to ICP variations. Some authors [10, 14] indicate that the ICP signal is 
formed by three overlapping components in the time domain with different frequencies. 
The first one is the pulse wave, with a fundamental frequency equal to the heart rate and 
several harmonics, all of them usually above 1 Hz [10, 14]. The second component is 
related to the respiratory cycle and can be generally found between 0.05 Hz and 0.2 Hz 
[10]. Finally, the third component is related to slow waves, with frequencies between 
0.0055 Hz and 0.05 Hz [10, 14]. Our findings support the notion that the components in 
bands 1B  and 2B  might be related to the respiratory wave and, especially, the pulse 
wave. Indeed, some authors have reported a heart rate above 60 beats per minute (bpm), 
corresponding to a frequency equal to 1 Hz (1 beat per second), for patients suffering 
from hydrocephalus. A baseline heart rate of 70  10 bpm, mean  standard deviation 
(SD) was found in 34 patients suffering from NPH, [33]. Similarly, a heart rate of 73  
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15 bpm (mean  SD) was reported for a database of 13 patients [34]. Heart rate has been 
also modelled as having a frequency of 70 bpm on a study on hydrocephalus valves 
[35]. These results indicate that the frequency of the pulse wave may be above 1 Hz in 
patients suffering from hydrocephalus and, thus, would mainly correspond to band B2 
(1Hz – 2 Hz) in this study. Respiratory waves have lower frequencies [3, 10] and, thus, 
would be primarily related to band B1 (0.1 Hz – 1 Hz).  
Further investigation is needed in order to confirm these relationships and determine 
whether frequencies below 0.1 Hz can provide additional information. However, very 
low frequency components recorded during infusion studies may not be strictly defined 
as slow waves, as in a more general ICP analysis context. ICP slow waves, known as 
Lundberg’s ‘B’ waves, are usually analysed in overnight ICP, since they are associated 
with cerebral pathological conditions [36, 37]. There is evidence that frequent presence 
of this type of waves may result in a positive response to shunting [38]. In the case of 
infusion studies, the recording time is much shorter and patients are awake [10]. 
Therefore, very low frequency components in infusion studies may not reveal the same 
information as in overnight recordings [5]. Likewise, results regarding the presence of 
slow waves are sometimes contradictory. A reduced activity of slow waves was found 
to be associated with poor prognosis after traumatic brain injury [39], whereas other 
authors suggested that the occurrence of plateau slow waves was not directly linked to 
worse outcome in head injured patients [36]. Finally, ‘B’ waves have been also 
observed in healthy subjects [18, 40]. 
Results in Table 2 also show that, during the infusion study, 
2B
RP  increased while 
1B
RP  decreased with respect to the basal phase. Therefore, under the increase in ICP 
induced by infusion, the signal spectrum is shifted towards higher frequencies with 
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respect to the basal state. As a consequence, MF is higher in the plateau phase (see 
Table 2). This result indicates that the arterial component of the pressure wave becomes 
more prominent in the plateau phase. This issue could be explained taking into account 
different effects. In the first place, it could be explained from the hypothesis of the 
activation of an intracranial baroreflex channelled through the autonomic system, as 
suggested in [33]. Results in this study showed that the moderate rise in ICP during 
infusion studies yielded a reversible pressure-mediated systemic response that consists 
in an increase in arterial blood pressure (ABP). This effect also influenced cerebral 
perfusion pressure (CPP), defined as the mean ABP minus ICP, which significantly 
decreased during infusion tests [33]. The Cushing response could compromise CPP in 
an advanced stage. However, before this extreme stage is reached, haemodynamic 
changes associated to intracranial hypertension could develop [33]. These changes are 
compatible with an early Cushing response: moderate rise in ABP, mild decrease in 
CPP, reduction of cerebral blood flow and increase in the heart rate variability without a 
modification of its mean value [33]. These effects might influence the ICP waveform 
producing an increase in 
2B
RP  during infusion. 
In the second place, the rise in ICP induced by the infusion test may affect the 
compliance of the brain and cerebral blood vessels. Vascular compliance is important in 
the brain because it is surrounded by a rigid container (the skull) and an incompressible 
fluid (CSF) [41]. It is generally accepted that the oscillation of ICP with the cardiac 
cycle is a result of the cardiac-driven variations in ABP [42]. The volume of intracranial 
blood varies along one cardiac cycle, due to the pulsatile nature of the blood supply in 
the brain: it increases during systole and decreases during diastole [41, 43]. The arterial 
pulsations are transmitted to the CSF and, thus, volume changes during the cardiac 
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cycle result also in changes in CSF [41]. As a consequence, the morphology of the CSF 
waveform suffers changes that depend on the arterial input, the compliance of the 
cranial contents (parenchyma and cerebral wall) and the blood flow towards the venous 
system [41, 44]. However, the relationship between ABP and ICP oscillation appears to 
be altered in clinically relevant conditions such as hypertension and hydrocephalus [42]. 
Under elevated ICP states, brain compliance decreases [14, 45] and this causes small 
changes in intracranial volume induced by cardiac pulsations to generate large ICP 
wave amplitudes [46]. The increase in 
2B
RP , together with the decrease in 
1B
RP , in the 
plateau phase with respect to the basal phase observed in the present study might reflect 
these alterations in the ICP waveform associated to changes in brain compliance. 
Finally, the increase in
2B
RP  in the plateau phase might be related to a breakdown of 
the windkessel mechanism induced by the increase in ICP during infusion. The 
windkessel mechanism refers to a progressive dissipation of arterial pulsations, mostly 
through the CSF, to reach the capillary circulation almost pulseless [47]. Adequate 
functioning of the windkessel mechanism appears to be necessary for normal cerebral 
blood flow [47, 48]. However, the increase in ICP induced by infusion tests might alter 
the biomechanics of the brain and cause a breakdown of the windkessel mechanism 
[47]. As a consequence, the arterial pulse pressure delivered to the capillary circulation 
would be stronger [47]. This effect should be reflected in changes in the arterial 
component during infusion, which is consistent with the increase in 
2B
RP  observed in 
the plateau phase. 
In a second stage of the present study, the correlation between spectral parameters 
and several demographic, radiological and ICP-based variables was analysed. Results in 
Table 4 show that only a few significant correlations could be found. These were related 
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to the amplitude of the signal in the basal and plateau phase ( oA  and pA , respectively). 
It is noteworthy that, in the case of 
2B
RP , significant correlations were found with pA  in 
all the artefact-free epochs of the infusion study. This result suggests that frequency 
components in 2B , mainly connected to the pulse component of ICP signals, are 
directly related to the increase in ICP produced during intracranial hypertension. The 
relationship between the pulse amplitude of ICP (amplitude of the first harmonic of the 
pulse component) and the mean pressure recorded during infusion studies has been also 
observed in previous studies [10, 11, 14]. Our findings also indicate that there is a close 
relationship between ICP values that can be reached during infusion studies (quantified 
by pA ) and the percentage of the total signal power in band 2B . 
Previous studies have also addressed the characterisation of ICP signals. In previous 
studies from our research group [7, 49], non-linear analysis of data recorded during 
infusion studies was accomplished. Results showed that the CSF pulse waveform 
complexity significantly decreased, while CSF pulse waveform variability significantly 
increased, during the period of intracranial hypertension (plateau phase) with respect to 
the basal phase. ICP signals have been also studied in the frequency domain using very 
different strategies. The FT of ICP signals was analysed in the context of the pulse 
amplitude of ICP, as a means of characterising ICP waveform [11, 19]. Other 
researchers tried to reconstruct the ICP signal from the information in the first harmonic 
of the FT of the signal [20]. They compared the raw signal and the reconstructed signal 
in order to quantify the amount of information that was lost in this process. Slow waves 
have been also studied in order to separate them from other components of the ICP 
signal and appropriately define the frequency boundaries between different types of 
slow waves [18, 38]. The relationship between the different vasogenic components of 
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ICP signals and R  was analysed in [10]. In this study, data were recorded during 
infusion studies for patients with hydrocephalus. However, signals in [11, 18, 20, 38] 
did not come from infusion tests. Thus, a direct comparison with our study is not 
straightforward. 
Other indexes derived from Fourier analysis of ICP signals have been previously 
studied. Some researchers calculated the amplitude of the first harmonic of the pulse 
component and the power of slow waves after a FT analysis for the basal and plateau 
phases of infusion tests [10]. The pressure-volume compensatory reserve index (RAP 
index) has been also analysed in previous studies, as the correlation coefficient between 
the amplitude and mean pressure of the first harmonic of the pulse waveform [14, 39]. 
The spectral parameters analysed in the present study are different from these. Firstly, 
MF, 
1B
RP ,
2B
RP and 
3B
RP  were calculated from the PSD of the signals, rather than from 
a direct calculation of the FT. Secondly, the PSD was calculated as the FT of the 
autocorrelation function using the moving window technique, more adequate for non-
stationary signals [26, 27]. The spectral parameters calculated in this study can be 
regarded as complementary measures to the previous indexes, since they provide 
distinct measures from the ICP waveform. The extraction of simple spectral parameters, 
such as MF and RP, is a necessary first step to introduce this alternative framework to 
understand brain dynamics in hydrocephalus. Besides, RP and MF are easy to interpret 
and summarise different characteristics of the PSD. Therefore, these measures provide a 
preliminary description of ICP signal spectra that could be extended in future studies by 
the inclusion of additional spectral parameters that quantify other features of the ICP 
signals. 
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Finally, some technical and clinical issues merit further consideration. The ICP 
waveform can be divided into several components (pulse wave, respiratory wave and 
slow waves) primarily related to changes in cerebral blood volume [7]. Hence, ICP 
signals should be studied together with ABP signals or heart rate signals in order to 
obtain a better understanding of their relationship in the frequency domain and the 
influence of these components in the bands of interest. These additional signals might 
also be helpful in better defining the bands of interest for the spectral analysis of ICP 
signals in infusion studies. Besides, frequencies below 0.1 Hz were not analysed in this 
study. ICP signals were filtered below this frequency in order to avoid the influence of 
the DC component. Additionally, the spectral resolution of the calculated PSDs 
hindered the separation of the DC component from very low frequency components. 
Further research should be carried out to explore whether these frequencies contain 
useful information in signals recorded during infusion tests and their possible 
relationship with slow waves in overnight recordings. It should also be noted that the 
early infusion phase is a transient state between the basal and plateau phases. Although 
it is not a steady state, like the remaining phases of the infusion test, the spectral 
analysis in this stage provided useful information about the trend of the changes in the 
analysed spectral parameters between the basal and plateau phases. Another limitation 
of the study is related to the population under study. Spectral analysis was performed on 
a heterogeneous group of patients who showed clinical and radiological features of 
NPH. The database encompasses a wide range of ages and mechanisms leading to 
hydrocephalus. However, we consider that heterogeneity in patient population should 
not be regarded as a serious drawback, since the aim of this study was to analyse 
alternative spectral methods in deriving new measures from ICP signals. Finally, it 
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should be pointed out that it would be desirable to test the proposed method on a larger 
set of ICP signals. 
In summary, spectral parameters like MF and RP reveal changes in the ICP signal 
spectrum during stress episodes. Significant differences were found between most 
phases of the infusion test using MF. Besides, significant differences between all phases 
of the infusion study could be found using 
1B
RP  and 
2B
RP . Differences were not 
statistically significant in the case of 
3B
RP . The increase of MF and 
2B
RP , together with 
the decrease of 
1B
RP , in the plateau phase with respect to the basal phase indicate that 
the signal spectrum is shifted towards higher frequencies under raised ICP conditions. 
Statistically significant relationships with amplitude in the basal and plateau phases 
were also found using these spectral methods. More specifically, significant correlations 
were found for A0 vs.MF0, A0 vs. 0
3B
RP , Ap vs. 1
1B
RP , Ap vs. 0
2B
RP , Ap vs. 1
2B
RP , Ap 
vs. 2
2B
RP  and Ap vs. 3
2B
RP . These findings indicate that spectral analysis could help to 
understand CSF dynamics during infusion tests.  
Future efforts will be aimed at studying new spectral parameters in order to 
determine whether they can reveal differences between stages of the infusion test, as 
well as more significant correlations between spectral parameters and clinical data. The 
use of different time-frequency representations with variable time-frequency resolution, 
such as wavelets, would also be addressed in order to appropriately study very low 
frequency components that might be associated with slow waves. We will also try to 
combine the information of spectral and non-linear analysis of ICP signals, in order to 
obtain complementary information that might help physicians to better understand CSF 
dynamics in hydrocephalus. Finally, the potential clinical applications of these results 
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need to be further explored, since this study is a first step towards the potential use of 
these spectral parameters in the clinical practise. In this sense, it would be desirable to 
assess the utility of spectral analysis of ICP signals in the prediction of patient response 
to shunting and in the distinction between hydrocephalus and other pathological states 
with similar clinical signs. 
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APPENDIX A. ABBREVIATIONS AND SYMBOLS 
A1. Abbreviations 
ABP Arterial blood pressure 
CPP Cerebral perfusion pressure 
CSF Cerebrospinal fluid 
DC Direct current 
DTFS Discrete time Fourier series 
FIR Finite impulse response 
FT Fourier transform 
ICP Intracranial pressure 
NPH Normal pressure hydrocephalus 
PSD Power spectral density 
RAP Pressure-volume compensatory reserve index 
SD Standard deviation 
STA Short-time autocorrelation 
STFT Short time Fourier transform 
 
A2. Symbols and units 
Symbol Definition Units 
A0 Basal amplitude of the CSF pressure signal (mm Hg) 
Ap Plateau amplitude of the CSF pressure signal (mm Hg) 
B1 Frequency band 1 (0.1 Hz – 1 Hz) (Hz – Hz) 
B2 Frequency band 2 (1 Hz – 2 Hz) (Hz – Hz) 
B3 Frequency band 3 (2 Hz – 3 Hz) (Hz – Hz) 
E Evans index - 
fs Sampling frequency (Hz) 
IR Infusion rate (ml min
-1
) 
L Length of 5-s segments (# of samples) 
MF Median frequency (Hz) 
MF0 Median frequency in the basal phase  (Hz) 
MF1 Median frequency in the early infusion phase (Hz) 
MF2 Median frequency in the plateau phase (Hz) 
MF3 Median frequency in the recovery phase (Hz) 
N Length of discrete-time signal (# of samples) 
NT Number of 5-s segments in a signal (# of segments) 
P0 Basal CSF pressure (mm Hg) 
Pp Plateau CSF pressure (mm Hg) 
R CSF outflow resistance (mm Hg ml
-1
 min) 
 28 
RP Relative power (%) 
0
jB
RP  
Relative power in the basal phase and for frequency 
band jB  ( 3,2,1j ) 
(%) 
1
jB
RP  
Relative power in the early infusion phase and for 
frequency band jB  ( 3,2,1j ) 
(%) 
2
jB
RP  
Relative power in the plateau phase and for 
frequency band jB  ( 3,2,1j ) 
(%) 
3
jB
RP  
Relative power in the recovery phase and for 
frequency band jB  ( 3,2,1j ) 
(%) 
Ts Sampling period (s) 
α Significance level - 
Ω0 Fundamental frequency (rad) 
Ω Discrete frequency (rad) 
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TABLE CAPTIONS 
 
Table 1.- Data recorded from the population under study. 
 
Table 2.- Median [interquartile range, IQR] values of the epoch length, CSF pressure 
and spectral parameters (MF, 
1B
RP , 
2B
RP  and 
3B
RP ) for each artefact-free epoch in the 
infusion tests. 
 
Table 3.- Z statistics and p-values associated to the Wilcoxon tests for MF, 
1B
RP  and 
2B
RP . The significant values (
31070.1 p , Bonferroni-corrected) have been 
highlighted. 
 
Table 4.-. Correlation coefficients (r) and p-values obtained for the Spearman test to 
analyse the relationship between spectral parameters and patient data. Values with a 
significance level 01.0p  are highlighted. 
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FIGURE LEGENDS 
 
Figure 1. (a) Evolution of the CSF pressure values in an infusion study for a patient with 
a proposed diagnosis of normal pressure hydrocephalus. The four artefact-free epochs 
selected by the neurosurgeon have been depicted (E0: epoch 0, E1: epoch 1, E2: epoch 
2, E3: epoch 3). (b) Temporal variation of median frequency (MF) for the ICP signal 
shown above. (c) Temporal variation of relative power (RP) in the three bands of 
interest for the ICP signal shown above. 
 
